Previous Article | Next Article ![]()
Journal of Virology, June 2000, p. 5452-5459, Vol. 74, No. 12
Department of Infectious Diseases1
and Department of Viral Infection,2
Institute of Medical Science, University of Tokyo, St.
Marianna University School of Medicine,3
AIDS Research Center, National Institute of Infectious
Diseases,4 AIDS Clinical Center,
International Medical Center of Japan,5 and
Department of Infectious Diseases, Tokyo Metropolitan
Komagome Hospital,6 Tokyo, Japan
Received 29 July 1999/Accepted 21 March 2000
The emergence of syncytium-inducing (SI) variants of human
immunodeficiency virus type 1 (HIV-1) in infected individuals is an
indicator of poor prognosis and is often correlated with faster CD4+ cell depletion and rapid disease progression.
Interleukin-4 (IL-4) is a pleiotropic cytokine with various
immune-modulating functions including induction of immunoglobulin E
(IgE) production in B cells, down-regulation of CCR5 (a coreceptor for
HIV-1 non-SI [NSI] strains), and up-regulation of CXCR4 (a coreceptor
for HIV-1 SI variants). Here we show that homozygosity of a
polymorphism in the IL-4 promoter region, IL-4
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Polymorphism in the Interleukin-4 Promoter Affects
Acquisition of Human Immunodeficiency Virus Type 1 Syncytium-Inducing Phenotype
589T, is correlated
with increased rates of SI variant acquisition in HIV-1-infected
individuals in Japan. This mutation was also shown to be associated
with elevated serum IgE levels in HIV-1-infected individuals,
especially in those at advanced stages of disease. In contrast, neither
a triallele polymorphism in IL-10, another Th2 cytokine, nor a biallele
polymorphism in the RANTES promoter affected acquisition of the SI
phenotype. This finding suggested that IL-4-589T increases IL-4
production in the human body and thus accelerates the phenotypic switch
of HIV-1 from NSI to SI and possibly disease progression of AIDS.
*
Corresponding author. Present address: Department of
Viral Infections, Research Institute for Microbial Diseases, Osaka
University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan. Phone:
81-6-6879-8346. Fax: 81-6-6879-8347. E-mail:
shioda{at}biken.osaka-u.ac.jp.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|